glyburide and quinazolines

glyburide has been researched along with quinazolines in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (40.00)	29.6817
2010's	5 (50.00)	24.3611
2020's	1 (10.00)	2.80

Authors

Authors	Studies
Antoine, MH; Becker, B; Damas, J; de Tullio, P; Delarge, J; Dupont, L; Fontaine, J; Lebrun, P; Ouedraogo, R; Pirotte, B; Rigo, B; Somers, F	1
Carvalho, LC; de Moura, RS; Madeira, SV; Miranda, DZ; Pinto, AC; Rangel, BM; Resende, AC; Rubenich, LM; Sicca, RF; Souza, MA; Tano, T	1
Costa, DB; Huberman, MS	1
Baker, JE; Fu, X; Gross, GJ; Hsu, A; Strande, JL; Su, J	1
Graefe-Mody, U; Iovino, M; Ring, A; Rose, P; Woerle, HJ; Zander, K	1
Ma, G; Wang, H; Yan, J; Yang, Q; Zhang, X; Zhu, X	1
Scheen, AJ	1
Aubdool, AA; Bátai, IZ; Brain, SD; Filotás, D; Hajna, Z; Helyes, Z; Nagy, L; Payrits, M; Pintér, E; Pozsgai, G; Sághy, É; Szőke, É	1
Abdelkader, NM; Abou-Seri, SM; Mohamed, MA; Taha, AM	1
Al-Marzooki, Z; Alasmari, MM; Alshaeri, HK; Bamanie, FH; El-Zahabi, MA; Ghareeb, S; Moustafa, M; Zayed, MF	1

Reviews

1 review(s) available for glyburide and quinazolines

Article	Year
Linagliptin for the treatment of type 2 diabetes (pharmacokinetic evaluation). Expert opinion on drug metabolism & toxicology, 2011, Volume: 7, Issue:12 Topics: Area Under Curve; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Glyburide; Humans; Hypoglycemic Agents; Linagliptin; Metformin; Pioglitazone; Purines; Quinazolines; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiazolidinediones	2011

Article

Year

Linagliptin for the treatment of type 2 diabetes (pharmacokinetic evaluation).

Expert opinion on drug metabolism & toxicology, 2011, Volume: 7, Issue:12

Topics: Area Under Curve; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Glyburide; Humans; Hypoglycemic Agents; Linagliptin; Metformin; Pioglitazone; Purines; Quinazolines; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiazolidinediones

2011

Trials

1 trial(s) available for glyburide and quinazolines

Article	Year
Assessment of the pharmacokinetic interaction between the novel DPP-4 inhibitor linagliptin and a sulfonylurea, glyburide, in healthy subjects. Drug metabolism and pharmacokinetics, 2011, Volume: 26, Issue:2 Topics: Adolescent; Adult; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Biological Availability; Cross-Over Studies; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Interactions; Female; Glyburide; Humans; Hypoglycemic Agents; Linagliptin; Male; Middle Aged; Purines; Quinazolines; Sulfonylurea Compounds	2011

Article

Year

Assessment of the pharmacokinetic interaction between the novel DPP-4 inhibitor linagliptin and a sulfonylurea, glyburide, in healthy subjects.

Drug metabolism and pharmacokinetics, 2011, Volume: 26, Issue:2

Topics: Adolescent; Adult; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Biological Availability; Cross-Over Studies; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Interactions; Female; Glyburide; Humans; Hypoglycemic Agents; Linagliptin; Male; Middle Aged; Purines; Quinazolines; Sulfonylurea Compounds

2011

Other Studies

8 other study(ies) available for glyburide and quinazolines

Article	Year
Original 2-alkylamino-6-halogenoquinazolin-4(3H)-ones and K(ATP) channel activity. Journal of medicinal chemistry, 2001, Aug-02, Volume: 44, Issue:16 Topics: Adenosine Triphosphate; Animals; Aorta; Calcium; Crystallography, X-Ray; Female; Glyburide; Guinea Pigs; Ileum; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Muscle Contraction; Muscle, Smooth; Potassium Channels; Potassium Chloride; Quinazolines; Rats; Rats, Wistar; Rubidium; Structure-Activity Relationship; Uterine Contraction; Uterus	2001
Mechanism of the endothelium-dependent vasodilation and the antihypertensive effect of Brazilian red wine. Journal of cardiovascular pharmacology, 2004, Volume: 44, Issue:3 Topics: Acetylcholine; Administration, Oral; Alcohol Drinking; Animals; Apamin; Atropine; Blood Pressure; Bradykinin; Brazil; Charybdotoxin; Clonidine; Deoxycholic Acid; Drug Therapy, Combination; Endothelium, Vascular; Flavonoids; Glyburide; Guanylate Cyclase; Hypertension; Indomethacin; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroglycerin; Norepinephrine; Oxadiazoles; Perfusion; Phenols; Polyphenols; Potassium Chloride; Pressure; Pyrilamine; Quinazolines; Quinoxalines; Rats; Rats, Wistar; Vasoconstriction; Vasodilation; Wine; Yohimbine	2004
Improvement of type 2 diabetes in a lung cancer patient treated with Erlotinib. Diabetes care, 2006, Volume: 29, Issue:7 Topics: Aged; Carcinoma, Non-Small-Cell Lung; Diabetes Mellitus, Type 2; Erlotinib Hydrochloride; Female; Glyburide; Humans; Lung Neoplasms; Pioglitazone; Quinazolines; Thiazolidinediones	2006
SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts. Basic research in cardiology, 2007, Volume: 102, Issue:4 Topics: Androstadienes; Animals; Cardiotonic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glyburide; Hirudins; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Oligopeptides; omega-N-Methylarginine; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Potassium Channel Blockers; Potassium Channels; Proto-Oncogene Proteins c-akt; Pyrroles; Quinazolines; Rats; Rats, Sprague-Dawley; Receptor, PAR-1; Recombinant Proteins; Research Design; RNA, Messenger; Signal Transduction; Thrombin; Time Factors; Ventricular Function, Left; Wortmannin	2007
Transport characteristics of tryptanthrin and its inhibitory effect on P-gp and MRP2 in Caco-2 cells. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2011, Volume: 14, Issue:3 Topics: Antitubercular Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Caco-2 Cells; Diffusion; Digoxin; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Enzyme Inhibitors; Glyburide; Humans; Hypoglycemic Agents; Intestinal Mucosa; Intestines; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Permeability; Quinazolines	2011
Capsaicin-Sensitive Sensory Nerves Mediate the Cellular and Microvascular Effects of H2S via TRPA1 Receptor Activation and Neuropeptide Release. Journal of molecular neuroscience : MN, 2016, Volume: 60, Issue:2 Topics: Animals; Calcitonin Gene-Related Peptide; Capsaicin; Cell Line; Cells, Cultured; Dipeptides; Diterpenes; Female; Glyburide; Hydrogen Sulfide; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neurokinin-1 Receptor Antagonists; Potassium Chloride; Quinazolines; Receptors, Neurokinin-1; Sensory Receptor Cells; Substance P; Transient Receptor Potential Channels; Trigeminal Ganglion; TRPA1 Cation Channel; Vasodilation	2016
New Quinazoline-Sulfonylurea Conjugates: Design, Synthesis and Hypoglycemic Activity. Medicinal chemistry (Shariqah (United Arab Emirates)), 2019, Aug-26, Volume: 15, Issue:6 Topics: Alloxan; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Down-Regulation; Female; Glucose Transporter Type 2; Glucose Transporter Type 4; Glyburide; Hypoglycemic Agents; Insulin; Insulin Receptor Substrate Proteins; Molecular Structure; Muscle, Skeletal; Pancreas; Quinazolines; Rats, Sprague-Dawley; Structure-Activity Relationship; Up-Regulation	2019
Design, Synthesis, Molecular Modeling and Anti-Hyperglycemic Evaluation of Quinazoline-Sulfonylurea Hybrids as Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) and Sulfonylurea Receptor (SUR) Agonists. International journal of molecular sciences, 2022, Aug-24, Volume: 23, Issue:17 Topics: Animals; Diabetes Mellitus, Experimental; Glyburide; Humans; Hypoglycemic Agents; Molecular Docking Simulation; PPAR gamma; Quinazolines; Rats; Sulfonylurea Compounds; Sulfonylurea Receptors	2022